Gsa Capital Partners LLP Ptc Therapeutics, Inc. Transaction History

Gsa Capital Partners LLP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$24.69 - $40.12 $423,458 - $688,098	17,151 Added 125.13%	30,858 $944,000
Q1 2024 May 03, 2024	BUY	$24.15 - $31.95 $331,024 - $437,938	13,707 New	13,707 $398,000
Q2 2022 Aug 09, 2022	SELL	$25.6 - $45.23 $336,947 - $595,317	-13,162 Reduced 54.47%	11,002 $441,000
Q1 2022 May 11, 2022	BUY	$33.33 - $44.6 $805,386 - $1.08 Million	24,164 New	24,164 $902,000
Q4 2021 Feb 14, 2022	SELL	$35.36 - $41.86 $609,571 - $721,624	-17,239 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$37.01 - $44.74 $638,015 - $771,272	17,239 New	17,239 $641,000
Q2 2021 Aug 05, 2021	SELL	$37.95 - $49.37 $324,093 - $421,619	-8,540 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$46.8 - $68.92 $399,672 - $588,576	8,540 New	8,540 $404,000
Q1 2020 May 12, 2020	SELL	$32.37 - $59.36 $191,436 - $351,055	-5,914 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$32.22 - $50.07 $190,549 - $296,113	5,914 New	5,914 $284,000
Q2 2019 Aug 06, 2019	SELL	$35.42 - $45.0 $1.09 Million - $1.39 Million	-30,832 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$28.09 - $39.49 $214,382 - $301,387	7,632 Added 32.9%	30,832 $1.16 Million
Q4 2018 Feb 12, 2019	SELL	$29.83 - $46.51 $163,766 - $255,339	-5,490 Reduced 19.14%	23,200 $796,000
Q3 2018 Nov 13, 2018	BUY	$33.9 - $47.77 $972,591 - $1.37 Million	28,690 New	28,690 $1.35 Million

221

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.28B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.